Heterotypic responses against nsp12/nsp13 from prior SARS-CoV-2 infection associates with lower subsequent endemic coronavirus incidence
Alternative Therapies in Health and Medicine , 27(4), 813
This remarkable pharmacokinetic synergy makes the combination especially valuable for advanced comparative studies, severe injury-recovery models, and highly complex regenerative research protocols where coordinated, multi-tissue repair is a primary focal point
This product is a dietary supplement and is not intended to diagnose, treat, cure, or prevent any disease
Populations at elevated risk are people on blood thinners, immune suppression, and those with severe kidney or liver disease